101495-62-9

Basic information

• Product Name: 2,4-Dichloro-5-nitro-benzoic acid Methyl ester
• Synonyms: 2,4-Dichloro-5-nitro-benzoic acid Methyl ester;Methyl 2,4-dichloro-5-nitrobenzoate
• CAS NO: 101495-62-9
• Molecular Formula: C₈H₅Cl₂NO₄
• Molecular Weight: 250.0356
• Mol File: 101495-62-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,4-Dichloro-5-nitro-benzoic acid Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Dichloro-5-nitro-benzoic acid Methyl ester(101495-62-9)
• EPA Substance Registry System: 2,4-Dichloro-5-nitro-benzoic acid Methyl ester(101495-62-9)

Safety Data

• Hazardous Substances Data: 101495-62-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2,4-Dichloro-5-nitro-benzoic acid Methyl ester is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its role in the production process is crucial for creating a range of medications that can address different health conditions.
Used in Agrochemical Industry:
In the agrochemical sector, 2,4-Dichloro-5-nitro-benzoic acid Methyl ester is utilized as an intermediate in the production of pesticides and herbicides. Its chemical properties make it a valuable component in the development of these agricultural products.
Used in Dye Industry:
2,4-Dichloro-5-nitro-benzoic acid Methyl ester is also employed as an intermediate in the synthesis of dyes, contributing to the colorfastness and vibrancy of various products in the textile and other industries that rely on colorants.
Used in Research Laboratories:
2,4-Dichloro-5-nitro-benzoic acid Methyl ester serves as a laboratory reagent for organic synthesis, aiding researchers in conducting experiments and developing new organic compounds.
Used in Neurological Treatments:
2,4-Dichloro-5-nitro-benzoic acid Methyl ester has shown potential as a selective acetylcholinesterase inhibitor, indicating its possible use in the treatment of neurological disorders and diseases. This application is still in the exploratory stage but holds promise for future therapeutic developments.

Upstream product

• 35112-28-8 methyl 2,4-dichlorobenzoate 
• 50-84-0 2,4 dichlorobenzoic acid 
• 67-56-1 methanol 
• 19861-62-2 2,4-dichloro-5-nitrobenzoic acid 

Downstream Products

• 1372129-85-5 N₁-(4'-cyanophenyl)-5-(2'',6''-dimethyl-4''-formylphenoxy)-4-methoxycarbonyl-2-nitroaniline 
• 1372129-84-4 5-chloro-N¹-(4-cyanophenyl)-4-methoxycarbonyl-2-nitroaniline 
• 1372407-05-0 C₂₆H₂₃N₅O₂ 
• 1372407-04-9 C₂₅H₂₁N₅O₂ 
• 1372407-03-8 C₂₅H₂₀N₄O₃ 
• 1372407-02-7 C₂₆H₂₂N₄O₃ 
• 1372407-01-6 N¹-(4-cyanophenyl)-5-(4'-cyanovinyl-2',6'-dimethylphenoxy)-4-hydroxymethyl-2-nitroaniline 
• 1372407-00-5 N₁-(4'-cyanophenyl)-5-(4''-(2-cyanovinyl)-2'',6''-dimethylphenoxy)-4-methylcarbamoyl-2-nitroaniline 
• 1372406-99-9 N₁-(4'-cyanophenyl)-5-(4''-(2-cyanovinyl)-2'',6''-dimethylphenoxy)-4-carbamoyl-2-nitroaniline 
• 1372406-98-8 N₁-(4'-cyanophenyl)-5-(4''-(2-cyanovinyl)-2'',6''-dimethylphenoxy)-4-carboxy-2-nitroaniline 
• 92964-32-4 4-Methoxy-5-nitro-2--benzoesaeure-methylester 
• 92554-43-3 4-Methoxy-5-nitro-2--benzoesaeure 
• 92554-34-2 4-Methoxy-5-nitro-2--benzoesaeure 
• 97441-98-0 4-Methoxy-5-nitro-2-(toluol-4-sulfonyl)-benzylalkohol 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.

AGRICULTURAL CHEMICALS

The present invention relates to compounds which are of use in the field of agriculture as herbicides. The invention also relates to methods of using said compounds and compositions comprising said compounds.

Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors

The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a series of new active DAAN derivatives 9a-9e, indicating an accessible modification approach that could improve anti-HIV potency against wild-type and resis

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates

Twenty-one new 4-substituted diarylaniline compounds (DAANs) (series 13, 14, and 15) were designed, synthesized, and evaluated against wildtype and drug resistant HIV-1 viral strains. As a result, approximately a dozen new DAANs showed high potency with l